RS
ANRO icon

R Squared’s Alto Neuroscience ANRO Stock Holding History

R Squared’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-140
Closed -$592 – 1549
2024
Q4 		$592 Buy
+140
New +$874 ﹤0.01% 1532

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

R Squared's ANRO Position: Q1 2025 in Review

R Squared sold out of Alto Neuroscience (ANRO) in Q1 2025, closing a stake of 140 shares — an estimated $592 sold.

R Squared first reported a position in ANRO in Q4 2024 and held it in 1 quarter. The position peaked at $592 in Q4 2024. 83 funds tracked by Wall St. Rank hold ANRO as of Q1 2025.

  • R Squared reported no remaining Alto Neuroscience position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 140 Alto Neuroscience shares in Q1 2025, an estimated $592.
  • R Squared first reported a position in Alto Neuroscience in Q4 2024 and held it in 1 quarter.
  • R Squared's Alto Neuroscience position peaked at $592 in Q4 2024.
  • 83 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.